A systematic exploration of bacterial secretion systems (Types I-VII), detailing how these varied protein export mechanisms dictate virulence and offer novel drug targets.
Compare Valsartan and Telmisartan. We detail the differences in duration of action, safety history, and unique metabolic effects for selecting the optimal ARB treatment.